Leads API and parenteral product analytical technology transfer from global partners to local CDMOs, managing method development/validation across clinical to commercial stages. Coordinate cross-functional teams to ensure seamless CDMO project execution.
Oversees analytical development and quality control activities at CRO/CDMOs, encompassing method development/transfer/validation, batch release testing, stability studies, troubleshooting, deviation investigations, and document review, while conducting on-site monitoring of analytical operations.
Drives analytical troubleshooting for assigned projects through independent method development/validation at Everest R&D lab.
Prepares and reviews regulatory submission documents (IND/NDA) and related filings as required.
Maintains scientific expertise through literature reviews, conference attendance, and continuous field monitoring.
Actively collaborates with other CMC Small Molecule team members to achieve organizational objectives.
任职条件
Chemistry/Pharmaceutical Sciences degree (Ph.D. with 10+ years or M.S. with 13+ years analytical R&D experience).
5+ years analytical R&D experience in small molecule injectables (experience with vaccines/ biologics is a strong plus).
Extensive hands-on experience in analytical method development/optimization/validation for both API and drug products.
Proficient in HPLC/UPLC operation; HRMS/CAD/ELSD/NMR experience preferred.
Thorough knowledge of ChP/USP/EP pharmacopeias and FDA/EMA/NMPA/ICH guidelines.
Fluent technical English reading/writing (IND/NDA documentation experience).
Strong cross-functional communication and team collaboration skills.